Madeos ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
301Macular dystrophy1

301. Macular dystrophy


Clinical trials : 46 Drugs : 42 - (DrugBank : 11) / Drug target genes : 9 - Drug target pathways : 67
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03297515
(ClinicalTrials.gov)
May 15, 201922/9/2017Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and Stargardt DiseaseProspective, Randomised, Double-blind Study to Assess the Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and Stargardt Disease (Macular Degeneration Omega-3 Study - MADEOSDry AMD;Stargardt Disease 1Dietary Supplement: Madeos;Dietary Supplement: PlaceboOphthalmos Research and Education InstituteNULLCompleted18 Years85 YearsAll32N/AFrance;Germany;Italy